Non-Small Cell

NSCLC Prognosis and Life Expectancy: Stage, Subtype, and Survival Outlook

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for approximately 80-85% of all lung cancer cases worldwide . Despite being the leading cause of cancer-related deaths, advances in early detection and treatment have gradually improved survival rates and patient outcomes . Understanding the prognosis of NSCLC is critical for guiding treatment decisions and helping patients and caregivers navigate the disease journey .